A STUDY OF THE SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF DRM01B TOPICAL GEL IN HEALTHY VOLUNTEERS AND SUBJECTS WITH ACNE VULGARIS
- Registry ID
- DRM01B-ACN01
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- DERMIRA INCORPORATED
- Start date
- 2013-08-08
- Last update
- 2013-07-31
Conditions
Related clinical trials
- A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, CLINICAL STUDY TO COMPARE THE SAFETY AND EFFICACY OF IDP-126 GEL TO EPIDUO FORTE GEL (0.3% ADAPALENE/2.5%BPO), IN THE TREATMENT OF ACNE VULGARIS
- A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-120 GEL AND IDP-120 VEHICLE GEL IN THE TREATMENT OF ACNE VULGARIS
- A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-120 GEL AND IDP-120 VEHICLE GEL IN THE TREATMENT OF ACNE VULGARIS
- AN OPEN-LABEL SAFETY AND PHARMACOKINETIC STUDY OF OLUMACOSTAT GLASARETIL GEL APPLIED UNDER MAXIMUM USE CONDITIONS IN PATIENTS WITH ACNE VULGARIS
- A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-123 LOTION AND IDP-123 VEHICLE LOTION IN THE TREATMENT OF ACNE VULGARIS
- A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-123 LOTION AND IDP-123 VEHICLE LOTION IN THE TREATMENT OF ACNE VULGARIS
View on source registry